DiaSorin (DIA) Investor presentation summary

Key healthcare challenges

• Rising costs and inflation have outpaced reimbursement increases, straining hospital finances and reducing reserves.

• Labor shortages are worsening as the workforce ages and retires faster than new staff can be trained.

• Reimbursement for molecular diagnostic panels is limited, especially for broad panels, impacting hospital profitability.

• Increasing test volumes and menu complexity add operational pressure to laboratories.

Diagnostic stewardship and laboratory strategies

• Diagnostic stewardship initiatives ensure the right test is ordered for the right patient at the right time, optimizing clinical value and reducing unnecessary testing.

• Institutions are developing algorithms to guide test selection, improving cost efficiency and staff productivity.

• Laboratories focus on cost optimization, automation, and flexible test selection to address operational challenges.

Flexible molecular testing solutions

• LIAISON PLEX® offers customizable multiplex panels, allowing selection of relevant targets based on patient profile, seasonality, and prevalence.

• Flex testing enables hospitals to save up to 40% in reagent costs by targeting only the most probable pathogens and reflexing to additional targets as needed.

• Customizable panels are in demand for gastrointestinal and blood culture testing, with broad pathogen coverage and adaptability for specific populations.